医院入院时存在中心静脉导管相关血流感染患者的特征:一项多中心研究
该研究回顾性横断面分析了2020年11月至2021年10月马里兰州、华盛顿特区和密苏里州11家医院中入院时存在中心静脉导管相关血流感染(CLABSI-POA)的461例患者,描述其人口学、临床特征与结局,并用Cox比例风险分析评估30天全因死亡相关因素。结果显示肠杆菌目为最常见病原体(29.2%),25%患者复发CLABSI,11%患者住院期间死亡;死亡风险随年龄增长和无保险而升高,随拔除中心静脉导管而降低。
要点
- CLABSI-POA患者中中心静脉导管最常用于家庭输液治疗(32.8%)或肿瘤门诊(31.2%)。
- 肠杆菌目是最常见病原体(29.2%),25%患者出现复发性CLABSI,11%患者住院期间死亡。
- 死亡风险随年龄增长和无保险升高,随拔除中心静脉导管降低。
核心结论
- CLABSI-POA与显著的住院死亡风险相关。
- 需要开展监测以了解社区中CLABSI的负担,从而确定急性护理机构之外CLABSI预防措施的目标。
研究设计与样本
- 回顾性横断面分析,纳入2020年11月至2021年10月马里兰州、华盛顿特区和密苏里州3个卫生系统共11家医院中CLABSI-POA患者。
- CLABSI-POA采用对急性护理CLABSI定义的改编版进行定义。
- 通过病历审查收集患者人口学、临床特征和结局,采用Cox比例风险分析评估30天全因死亡率相关因素。
主要发现
- 共识别461例CLABSI-POA患者,中心静脉导管最常用于家庭输液治疗(32.8%)或肿瘤门诊(31.2%)。
- 肠杆菌目为最常见病原体(29.2%),25%患者发生复发性CLABSI,11%患者住院期间死亡。
- 与年龄<20岁组相比,20-44岁组死亡风险比为11.2(95%CI 1.46-86.22),45-64岁组为20.88(95%CI 2.84-153.58),≥65岁组为22.50(95%CI 2.98-169.93)。
- 无保险与死亡风险升高相关(风险比2.46,95%CI 1.08-5.59),拔除中心静脉导管与死亡风险降低相关(风险比0.57,95%CI 0.39-0.84)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are no systematic measures of central line-associated bloodstream infections (CLABSIs) in patients maintaining central venous catheters (CVCs) outside acute care hospitals. To clarify the burden of CLABSIs in these patients, we characterized patients with CLABSI present on hospital admission (POA). METHODS: Retrospective cross-sectional analysis of patients with CLABSI-POA in 3 health systems covering 11 hospitals across Maryland, Washington DC, and Missouri from November 2020 to October 2021. CLABSI-POA was defined using an adaptation of the acute care CLABSI definition. Patient demographics, clinical characteristics, and outcomes were collected via record review. Cox proportional hazard analysis was used to assess factors associated with the all-cause mortality rate within 30 days. RESULTS: A total of 461 patients were identified as having CLABSI-POA. CVCs were most commonly maintained in home infusion therapy (32.8%) or oncology clinics (31.2%). Enterobacterales were the most common etiologic agent (29.2%). Recurrent CLABSIs occurred in a quarter of patients (25%). Eleven percent of patients died during the hospital admission. Among patients with CLABSI-POA, mortality risk increased with age (hazard ratio vs age <20 years by age group: 20-44 years, 11.2 [95% confidence interval, 1.46-86.22]; 45-64 years, 20.88 [2.84-153.58]; ≥65 years, 22.50 [2.98-169.93]) and lack of insurance (2.46 [1.08-5.59]), and it decreased with CVC removal (0.57 [.39-.84]). CONCLUSIONS: CLABSI-POA is associated with significant in-hospital mortality risk. Surveillance is required to understand the burden of CLABSI in the community to identify targets for CLABSI prevention initiatives outside acute care settings.
引用
- Oladapo-Shittu O, Cosgrove SE, Rock C, et al. Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study. Clin Infect Dis. 2024. PMID: 38483930. doi:10.1093/cid/ciae144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。